Cystic fibrosis in the Primorsky territory: achievements and challenges

Written by Vasilyeva T.G.

  UDK: 616.43-003.218-056.7(571.63) | Pages: 30–34 | Full text PDF | Open PDF 


Objective. A systematic analysis of certain aspects of the problem of cystic fibrosis (CF) is necessary to improve the quality of care requires.
Methods. The study involved 52 patients with CF: children – 66.5 %, adults – 33.5 %. We studied the structure of the gene mutations transmembrane conductance regulator (CFTR). The level of neonatal blood immunoreactive trypsin was defined in 72,746 newborns. It was examined the spectrum of bacterial pathogens, the state of the nutritional status of patients, the level of fecal elastase-1.
Results. The frequency of CF in the Primorsky territory – 2.69 per 100 thousand population. The frequency of birth of patients – 1 per 6,613 newborns. The average patient age 13.5±8.4. Among adult patients, 77.8 % of men. Among the dead children, girls accounted for 66.7 %. During the 17-year of follow-up verification of the terms of diagnosis decreased by 5.3 times. The structure of the allelic frequency prevails «severe» mutations in CFTR, often – F508del (53.7 %). In the structure of the microbial pathogen Pseudomonas aeruginosa and Staphylococcus aureus were verified more frequently. В 1,6 раза увеличилась частота выделения Burkholderia cepacia complex. Meconium ileus, rectal prolapse, weight deficiency, the severity of the disease and low levels of fecal elastase-1 are the objective criteria of exocrine pancreatic insufficiency degree. Only 61.4 % of the patients systematically implemented the recommendations for treatment and rehabilitation.
Conclusions. In Primorsky territory, there are opportunities for the timely diagnosis of CF, to determine risk factors that predict it in different age groups, carrying out and monitoring the efficiency of basic therapy. There remain problems with the practical awareness of doctors and patients about the risk groups, diagnostic capabilities and modern therapy.

Links to authors:

T.G. Vasilyeva
Regional Clinical Center of Specialized Types of Medical Care (30/37 Uborevicha St. Vladivostok 690091 Russian Federation)

1. Vasileva T.G., Kinyaykin M.F. Cystic fibrosis in adults: late manifistation or late diagnosis? // Cystic fibrosis. Interdisciplinary approach: materials of the 5th Annual North-West Scientific Conference. StP., 2014. P. 14–15.
2. Vasileva T.G., Shishatskaya S.N., Ni A.N. Some aspects of the respiratory and digestion defeat in cystic fibrosis in children // Current Pediatrics. 2013. Vol. 12, No. 1. P. 162–165.
3. Vasileva T.G., Shumatova T.A., Grigoryan S.V., Voronin S.V. Some aspects of the medical care to children with food intolerances // Pacific Medical Journal. 2015. No. 2. P. 33–36.
4. Voronina O.L., Chernukha M.Yu., Shaginyan I.A.[et al.]. Genotypes of Burkholderia cepacia complex, isolated from patients in hospitals of the Russian Federation // Molecular Genetics. 2013. No. 2. P. 22–30.
5. Gembitskaya T.E., Ivaschenko T.E., Chermenskiy A.G., Nasykhova Yu.A. Phenotypic features and genetic heterogeneity of patients with late manifestation and nonclassical course of cystic fibrosis // Pulmonology. 2014. No. 1. P. 66–70.
6. Kapranov N.I. Modern diagnostics, therapy and social adaptation of patients with cystic fibrosis in the Russian Federation // Pediatrics. 2014. Vol. 93, No. 4. P. 6–10.
7. Krasovskiy S.A., Chernyak A.V., Kashirskaya N.Yu. [et al.]. Cystic fibrosis in Russia: the creation of a national register // Pediatrics. 2014. Vol. 93, No. 4. P. 44–55.
8. Cystic fibrosis / edited by N.I. Kapranov, N.Yu. Kashirskiy. М.: Medpraktika-M, 2014. 672p.
9. The register of patients with cystic fibrosis in the Russian Federation. 2014. М.: Medpraktika-M, 2015. 64 p.
10. Tsyvkina G.I., Vasileva T.G., Grischenko D.Zh. The use of the immunotropic therapy for cystic fibrosis // Source book of the 16th Russian National Congress ‘Man and Medicine’. М., 2009. P. 466–467.
11. Döring G., Flume P., Heijerman H. [et al.]. Treatment of lung infection in patients with cystic fibrosis: current and future strategies // J. Cyst. Fibros. 2012. No.11. P. 461–479.
12. Mogayzel P.J., Naureckas E.T., Robinson K.A. [et al.]. Cystic Fibrosis Pulmonary Guidelines // Am. J. Respir. Crit. Care Med. 2013. No. 187. P. 680–689.
13. Smyth A.R., Bell S.C., Bojcin S. [et al.]. European Cystic Fibrosis Society Standards of Care: Best Practice guidelines // J. Cyst. Fibros. 2014. No. 13. P. 23–42.
14. Tramper-Stranders G.A., van der Ent C.K., Molin S. [et al.]. Initial Pseudomonas aeruginosa infection in patients with cystic fibrosis: characteristics of eradicated and persistent isolated et al. // Clin. Microbiol. Infect. 2012. Vol. 18, No. 6. P. 567–574.


Founded in 1997  |  Editions in a year: 4, Articles in one issue: 30 |  ISSN of print version: 1609-1175  |  Ind.: 18410 (Agency "Rospechat’")  |  Edition: 1000 c.